This is a routine proxy filing for an annual meeting with no earnings or operational news. The ISO share pool increase is immaterial. Monitor for any future 6-K or 20-F filing that may contain financial results or guidance updates.
KMDA drugs
KMDA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 18 $7.31entry
- T+1 · 5mo ago −1.64%α −1.33% · $7.19
- T+5 · 5mo ago −1.78%α −0.11% · $7.18
- T+20 · 4mo ago −5.47%α −6.00% · $6.91
- T+60 · 2mo ago +13.68%α +11.79% · $8.31
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Kamada Ltd. filed a 6-K on June 18, 2026, providing notice of its Annual General Meeting of Shareholders to be held on August 5, 2026. The meeting will cover routine director re-elections, approval of option grants to directors, an amendment to increase the ISO share reserve under the U.S. Taxpayers Appendix by 50,000 shares (to 550,000), and ratification of auditor EY. The filing also includes beneficial ownership data showing FIMI Funds (38.28%) and insiders (46.42%) as major holders. No financial results or material operational changes are disclosed.
Key Facts
- AGM scheduled for August 5, 2026, with record date June 23, 2026
- Proposal to increase ISO reserve under U.S. Taxpayers Appendix from 500,000 to 550,000 ordinary shares
- Options to purchase 30,000 ordinary shares proposed for each director nominee at exercise price NIS 22.87
- FIMI Opportunity Funds beneficially own 22,084,287 shares (38.28%) as of May 31, 2026
- Directors and executive officers as a group beneficially own 27,252,278 shares (46.42%)
- Audit fees for 2025: $420,000; total fees paid to EY: $514,226
Financial Impact
No material financial impact from this filing; the ISO share increase is a routine plan amendment with minimal dilution (50,000 shares on 57.7M outstanding, ~0.09% dilution)
Risk Factors
- No material risks identified in this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-069852 |
| Document: ea029492701ex99-2.htm | 0001213900-26-069852 |
| Document: ea0294927-6k_kamada.htm | 0001213900-26-069852 |
| Document: 0001213900-26-069852-index-headers.html | 0001213900-26-069852 |
| Document: 0001213900-26-069852-index.html | 0001213900-26-069852 |
| Document: 0001213900-26-069852.txt | 0001213900-26-069852 |
Track record
25 reports on KMDA
8 of 11 bullish or bearish reports moved the stock their way by T+5. Best: +16.13% at T+20 after the Aug 12, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 9, 20267d ago 6-K Bullish 6/10 No price data
- Nov 9, 20267d ago Press Release Bullish 6/10 Entry $7.71 to $8.11 Now $8.11 +5.19% ▲ +5.19% +6.88% vs SPY
- Nov 2, 202614d ago 6-K Neutral 2/10 Entry $7.36 to $7.71 Now $8.11 +10.19% ▲ +4.76% +4.68% vs SPY
- Oct 6, 20265w ago 6-K Neutral 4/10 Entry $8.11 to $7.69 Now $8.11 −0.00% ▼ −5.18% −5.04% vs SPY
- Oct 6, 20265w ago Press Release Bullish 6/10 Entry $8.11 to $7.69 Now $8.11 −0.00% ▼ −5.18% −5.04% vs SPY
- Oct 5, 20266w ago 6-K Neutral 2/10 Entry $8.11 to $7.69 Now $8.11 −0.00% ▼ −5.18% −5.04% vs SPY
- Sep 17, 20268w ago 6-K Bullish 6/10 Entry $8.67 to $8.83 Now $8.11 −6.46% ▲ +1.85% +1.24% vs SPY
- Sep 16, 20268w ago EFFECT Neutral 3/10 Entry $8.19 to $8.77 Now $8.11 −0.98% ▲ +7.08% +4.52% vs SPY
- Sep 10, 20269w ago 6-K Neutral 2/10 Entry $7.99 to $8.67 Now $8.11 +1.50% ▲ +8.51% +9.01% vs SPY
- Sep 3, 202610w ago Press Release Neutral 2/10 Entry $8.54 to $8.31 Now $8.11 −5.04% ▼ −2.69% −1.48% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers